Past Event

Combination Products 2017

28–29 September 2017
Boston, MA, United States
 

Course "Combination Products" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

 

Overview:

This seminar provides Professionals working in this area with

  • A thorough understanding of the complexities involved
  • All the relevant regulations and guidelines
  • Real life examples of how to register and maintain various types of combination products
  • Interfaces: Change Management and LCM
  • Compliant safety reporting for combination products
  • Documentation requirements and interfacing

 

Why you should attend :

 

Combination products are especially challenging to register and maintain since they consist of two or more regulated components covered by different and usually independent sets of regulations in both the EU and US and various other regions.

Delegates working in this area must keep abreast of current and new legislation in this complex area to ensure a good regulatory strategy and compliance of their products.

 

Areas Covered in the Session:

 

Documentation requirements and interfacing

  • Documentation requirements for combination products EU
  • Documentation requirements for combination products US
  • Interfacing, development, quality, regulatory
  • Managing third parties and document control.

 

Who Will Benefit:

 

  • Regulatory Affairs
  • Medical Officers
  • Clinical Trial Managers

 

Agenda:

 

 

Day 1 Schedule

 

Lecture 1:

A high level overview to Combination Products

Including an interactive group session reviewing individual expectations

Lecture 2:

Introduction to Drug/Device Regulations

During this introductory session, delegates will gain a complete guide to the status and impact of the latest guidelines for combination products. Examples (company specific) of combination products will also be discussed to gain insights into their variety and complexities. Regulatory Requirements for: US and EU

Lecture 3:

CE Marking, 510 K and PMAs general Overview

  • US and EU

Life Cycle Management

  • Interfaces: Change Management
  • CTA applications
  • Annual reporting

Lecture 4:

CASE STUDY 1 - Including a walkthrough of expected outcomes for all case study exercises

Wrap up of day 1 & Q&A's

 

Day 2 Schedule

 

Lecture 1:

Overview Combination product Regulation and CTD dossier requirments: EU and US (A comparative review)

Lecture 2:

Clarifying the regulatory requirements of combination products and addressing life-cycle management

  • Examining the regulatory requirements for drug device combinations in the case of a drug and a device and for integral products
  • Annual reports
  • Case studies

Lecture 3:

CASE STUDY 2

Lecture 4:

Compliant safety reporting for combination products

  • Taking into account your product's combined components when addressing adverse event reporting

Documentation requirements and interfacing

  • Documentation requirements for combination products EU
  • Documentation requirements for combination products US
  • Interfacing, development, quality, regulatory
  • Managing third parties and document control.

CASE STUDY 3

Wrap up of day 2

Final Q&A & Summary of 'working smart' with Combination Products

 

 

Speaker

Salma Michor

PhD, MSc, MBA, CMgr, RAC 

 

Salma Michor is founder and CEO of Michor Consulting Schweiz GmbH, serving such clients as Johnson & Johnson, Novartis, Shire, Pfizer and Colgate Palmolive. Previously, Michor worked for Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH. She teaches regulatory affairs and clinical strategies at the University of Krems, Austria, and is an independent expert to the European Commission. She holds a PhD in thermal process engineering and an MSc in food and biotechnology from the University of Applied Life Sciences in Vienna, Austria; an MSc from King's College, University of London in food technology; and an MBA from Open University, and has earned the RAC (EU), CQA and is a Chartered manager.

 

Location: Boston, MA Date:  September 28th & 29th, 2017 and Time: 9:00 AM to 5:00 PM

Venue:   Embassy Suites Boston Logan Airport   207 Porter Street Boston, MA 02128

 

 

Price:

 

Register now and save $200. (Early Bird)

Price: $1,295.00 (Seminar Fee for One Delegate)

Until August 10, Early Bird Price: $1,295.00 From August 11 to September 28, Regular Price: $1,495.00

Register for 5 attendees   Price: $3,885.00      $6,475.00 You Save: $2,590.00 (40%)*

 

Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar

At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.

As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.

For More Information- https://www.globalcompliancepanel.com/control/sponsorship 

 

Contact us today!

 

NetZealous LLC DBA GlobalCompliancePanel

john.robinson@globalcompliancepanel.com  

support@globalcompliancepanel.com 

Toll free: 1-800-447-9407

Phone: 1-510-584-9661

 Website: http://www.globalcompliancepanel.com

 

Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901066SEMINAR?globaleventslist-September-2017-SEO

 

Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/

Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/

Follow us on Twitter: https://twitter.com/GCPanel

 

Related Events

Comments